10-K Filing

AGILON HEALTH, INC. CIK: 1831097 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001628280-24-007242`
Period End Date	20231231
Filing Date	20240227
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	agl-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 76 Income Statement 79 Cash Flow Statement 123 Stockholders Equity 44 Comprehensive Income 18

Balance Sheet 76 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.57M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$465.30M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$6.76M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$10.61M	USD	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$411.90M	USD	Point-in-time
Marketable securities	`DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent`	$380.77M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$492.36M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$942.46M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$42.51M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$31.57M	USD	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$39.52M	USD	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	406.39M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	412.38M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	406.39M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.48B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.45B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.58M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$19.94M	USD	Point-in-time
Assets	`Assets`	$1.70B	USD	Point-in-time
Assets	`Assets`	$1.74B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$63.77M	USD	Point-in-time
Liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Liabilities	`Liabilities`	$1.08B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$18.45M	USD	Point-in-time
Goodwill	`Goodwill`	$2.51M	USD	Point-in-time
Goodwill	`Goodwill`	$24.13M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$145.31M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$105.86M	USD	Point-in-time
Non-current assets of discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	-	USD	Point-in-time
Non-current assets of discontinued operations	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$99.44M	USD	Point-in-time
Total assets	`Assets`	$1.70B	USD	Point-in-time
Total assets	`Assets`	$1.74B	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$300.80M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$737.72M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$233.18M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$177.43M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$6.25M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$51.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$535.09M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$977.16M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$38.48M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$32.31M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$82.49M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$70.38M	USD	Point-in-time
Non-current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Non-current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$794.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$656.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.08B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 406,387 and 412,385 shares issued and outstanding, respectively	`CommonStockValue`	$4.12M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 406,387 and 412,385 shares issued and outstanding, respectively	`CommonStockValue`	$4.06M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.99B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.11B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.06B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.33B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.56M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.30M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$661.84M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.04B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-611.00K	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-818.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$661.02M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Total liabilities and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.74B	USD	Point-in-time
Total liabilities and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.70B	USD	Point-in-time

Income Statement 79 line items

Line Item	Tag	Value	Unit	Period
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$28.07M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$291.67M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$69.33M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.60M	USD	Point-in-time
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.39B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.52B	USD	Annual
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.32B	USD	Annual
General and administrative (including noncash stock-based compensation expense of $69,326, $28,069, and $291,672, respectively)	`GeneralAndAdministrativeExpense`	$207.79M	USD	Annual
General and administrative (including noncash stock-based compensation expense of $69,326, $28,069, and $291,672, respectively)	`GeneralAndAdministrativeExpense`	$427.50M	USD	Annual
General and administrative (including noncash stock-based compensation expense of $69,326, $28,069, and $291,672, respectively)	`GeneralAndAdministrativeExpense`	$285.76M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$10.48M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$8.95M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$16.04M	USD	Annual
Total expenses	`CostsAndExpenses`	$4.55B	USD	Annual
Total expenses	`CostsAndExpenses`	$1.89B	USD	Annual
Total expenses	`CostsAndExpenses`	$2.49B	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-372.24M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-105.38M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-232.13M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$10.72M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$16.49M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-6.77M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$27.84M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$13.93M	USD	Annual
Other income (expense), net	`NonoperatingIncomeExpense`	$2.18M	USD	Annual
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	Annual
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	-	USD	Annual
Gain (loss) on lease terminations	`GainLossOnTerminationOfLease`	$-5.46M	USD	Annual
Interest expense	`InterestExpense`	$6.15M	USD	Annual
Interest expense	`InterestExpense`	$6.66M	USD	Annual
Interest expense	`InterestExpense`	$4.48M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-382.98M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-90.67M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-194.46M	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$791.00K	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$886.00K	USD	Annual
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$1.64M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-383.86M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-195.25M	USD	Annual
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-92.31M	USD	Annual
Income (loss) before gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-14.53M	USD	Annual
Income (loss) before gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-25.09M	USD	Annual
Income (loss) before gain (loss) on sales and income taxes	`DiscontinuedOperationsIncomeLossBeforeImpairmentsGainLossOnSalesAndIncomeTaxes`	$-20.00M	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax`	$473.00K	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax`	-	USD	Annual
Gain (loss) on sales of assets, net	`DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax`	$-47.55M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.69M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$26.00K	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-67.55M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-14.55M	USD	Annual
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-22.93M	USD	Annual
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-262.80M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-300.00K	USD	Annual
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-311.00K	USD	Annual
Noncontrolling interests share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-207.00K	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-406.49M	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-106.55M	USD	Annual
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-262.60M	USD	Annual
Continuing operations basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.22	USD	Annual
Continuing operations basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.48	USD	Annual
Continuing operations basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.03	USD	Annual
Continuing operations diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.48	USD	Annual
Continuing operations diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.22	USD	Annual
Continuing operations diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.03	USD	Annual
Discontinued operations basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	$-0.06	USD	Annual
Discontinued operations basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	$-0.16	USD	Annual
Discontinued operations basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	$-0.04	USD	Annual
Discontinued operations diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	$-0.16	USD	Annual
Discontinued operations diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	$-0.06	USD	Annual
Discontinued operations diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	$-0.04	USD	Annual
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	408.92M	shares	Annual
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	408.15M	shares	Annual
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	372.93M	shares	Annual
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	372.93M	shares	Annual
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	408.92M	shares	Annual
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	408.15M	shares	Annual

Cash Flow Statement 123 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-262.80M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.16M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.77M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.67M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$28.38M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$292.39M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$69.50M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.59M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$10.72M	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$16.49M	USD	Annual
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-6.77M	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$-532.00K	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	-	USD	Annual
Deferred income taxes and uncertain tax positions	`DeferredIncomeTaxesAndUncertainTaxPositions`	$3.23M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	-	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-1.71M	USD	Annual
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-553.00K	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	$-47.55M	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	$473.00K	USD	Annual
(Gain) loss on sale of assets, net	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	-	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	$-174.00K	USD	Annual
Distributions of earnings from equity method investments	`DistributionsOfEarningsFromEquityMethodInvestments`	-	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$-58.00K	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$-2.97M	USD	Annual
Other non-cash items	`OtherNoncashIncomeExpense`	$4.04M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$204.17M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$149.04M	USD	Annual
Receivables, net	`IncreaseDecreaseInReceivables`	$460.37M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.12M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.92M	USD	Annual
Prepaid expense and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$16.62M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$397.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$205.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-3.93M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-76.34M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-441.50M	USD	Annual
Medical claims and related payables	`IncreaseDecreaseInMedicalClaimsAndRelatedPayables`	$-107.71M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$19.36M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$32.11M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$65.74M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-16.80M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.70M	USD	Annual
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-11.89M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-156.20M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-130.81M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-148.16M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.83M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.56M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.43M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$6.86M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$14.98M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$17.23M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$82.83M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$6.51M	USD	Annual
Investments in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$19.53M	USD	Annual
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	$114.66M	USD	Annual
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	Annual
Investments in marketable securities	`PaymentsToAcquireMarketableSecurities`	$458.26M	USD	Annual
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$7.09M	USD	Annual
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$52.55M	USD	Annual
Proceeds from maturities and sales of marketable securities and other	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$164.04M	USD	Annual
Net cash paid in business combination	`NetCashPaidInBusinessCombination`	$45.25M	USD	Annual
Net cash paid in business combination	`NetCashPaidInBusinessCombination`	-	USD	Annual
Net cash paid in business combination	`NetCashPaidInBusinessCombination`	-	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$500.00K	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.34M	USD	Annual
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$2.19M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-90.51M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-444.39M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-44.02M	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	Annual
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$1.17B	USD	Annual
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$11.87M	USD	Annual
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$33.06M	USD	Annual
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$18.09M	USD	Annual
Common stock repurchase	`PaymentsForRepurchaseOfEquity`	$200.00M	USD	Annual
Common stock repurchase	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Common stock repurchase	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$5.00M	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$5.00M	USD	Annual
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$119.90M	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Equity and debt issuance costs and other	`PaymentsOfDebtIssuanceCosts`	$14.74M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.15B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-193.13M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.06M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-393.35M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-547.14M	USD	Annual
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$915.73M	USD	Annual
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$128.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$475.91M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.33M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$10.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$5.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$31.77M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$114.33M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$128.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$475.91M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.33M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$10.89M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$5.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$31.77M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$507.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$114.33M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.05B	USD	Point-in-time

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Beginning balance (in shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO") (in shares)	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	-76.20M	shares	Annual
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO")	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$-309.50M	USD	Annual
Ending balance (in shares)	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Ending balance (in shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	406.39M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$661.02M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-262.80M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Reclassification of contingently redeemable common stock in connection with initial public offering ("IPO")	`AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock`	$-309.50M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$3.26M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-5.56M	USD	Annual
Issuance of common stock in connection with IPO, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	9.30M	shares	Annual
Issuance of common stock in connection with IPO, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	11.70M	shares	Point-in-time
Issuance of common stock in connection with IPO, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$1.16B	USD	Annual
Issuance of common stock under partner physician group equity agreements upon IPO	`IssuanceOfCommonStockValueUnderPartnersEquityAgreement`	$268.47M	USD	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$18.09M	USD	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.71M	USD	Annual
Exercises and vesting of stock-based awards	`StockIssuedDuringPeriodValueStockOptionsExercised`	$33.89M	USD	Annual
Vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	Annual
Vesting of restricted stock units	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	Annual
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.85M	USD	Annual
Shares withheld related to net share settlement	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$831.00K	USD	Annual
Common stock repurchase (in shares)	`StockRepurchasedDuringPeriodShares`	9.60M	shares	Annual
Common stock repurchase	`StockRepurchasedDuringPeriodValue`	$201.41M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$69.50M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$23.93M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$28.38M	USD	Annual
Ending balance (in shares)	`CommonStockSharesOutstanding`	406.39M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	412.38M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.09B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$661.02M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.04B	USD	Point-in-time

Comprehensive Income 18 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-406.79M	USD	Annual
Net income (loss)	`ProfitLoss`	$-262.80M	USD	Annual
Net income (loss)	`ProfitLoss`	$-106.86M	USD	Annual
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax`	$-5.56M	USD	Annual
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax`	-	USD	Annual
Net unrealized gain (loss) on marketable securities, net of tax	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax`	$3.18M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$79.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-112.42M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-259.54M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-406.79M	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-311.00K	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-300.00K	USD	Annual
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-207.00K	USD	Annual
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-259.33M	USD	Annual
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-112.11M	USD	Annual
Total comprehensive income (loss) attributable to agilon health, inc.	`ComprehensiveIncomeNetOfTax`	$-406.49M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.